Linkage of malignant hyperthermia and hyperkalemic periodic paralysis to the adult skeletal muscle sodium channel (SCN4A) gene in a large pedigree
- PMID: 9508059
Linkage of malignant hyperthermia and hyperkalemic periodic paralysis to the adult skeletal muscle sodium channel (SCN4A) gene in a large pedigree
Abstract
Hyperkalemic periodic paralysis (HPP) is caused by mutations of the adult skeletal muscle sodium channel (SCN4A) gene on chromosome 17. Malignant hyperthermia (MH) is a genetically heterogeneous autosomal-dominant disorder occurring in association with various neuromuscular diseases or without other apparent abnormalities. In some families, MH is associated with mutations of a calcium release channel (RYR1) gene on chromosome 19. In other families, linkage of this disorder to the SCN4A gene on chromosome 17 has been suggested. We report on linkage analysis in a family in which both HPP and MH are inherited as autosomal-dominant traits. Two polymorphisms within the SCN4A locus, an RFLP and a (C-A)n repeat, were typed on multiple family members. The findings were consistent with linkage of the polymorphic markers within the SCN4A gene to both HPP (Zmax = 6.79 at theta = 0.0) and MH (Zmax = 1.76 at theta = 0) in this family. Our data provide further evidence that MH is linked to the SCN4A locus in some families.
Similar articles
-
Paramyotonia congenita and hyperkalemic periodic paralysis are linked to the adult muscle sodium channel gene.Ann Neurol. 1991 Dec;30(6):810-6. doi: 10.1002/ana.410300610. Ann Neurol. 1991. PMID: 1686388
-
Hyperkalemic periodic paralysis caused by recurring mutation in the adult muscle sodium channel alpha-subunit gene.Genet Couns. 1996;7(4):267-75. Genet Couns. 1996. PMID: 8985730
-
Ryanodine receptor gene is a candidate for predisposition to malignant hyperthermia.Nature. 1990 Feb 8;343(6258):559-61. doi: 10.1038/343559a0. Nature. 1990. PMID: 1967823
-
[Familial hyperkalemic periodic paralysis: a brief review of the adult human skeletal muscle sodium channel and the application of LA-PCR to the SCN4A gene analysis].Nihon Rinsho. 1997 Dec;55(12):3253-8. Nihon Rinsho. 1997. PMID: 9436446 Review. Japanese.
-
The role of the skeletal muscle ryanodine receptor gene in malignant hyperthermia.Symp Soc Exp Biol. 1992;46:189-201. Symp Soc Exp Biol. 1992. PMID: 1341035 Review.
Cited by
-
A Single-Center Retrospective Review of Patients with Suspected Malignant Hyperthermia Susceptibility.Cureus. 2023 Sep 4;15(9):e44661. doi: 10.7759/cureus.44661. eCollection 2023 Sep. Cureus. 2023. PMID: 37799222 Free PMC article.
-
Unraveling monogenic channelopathies and their implications for complex polygenic disease.Am J Hum Genet. 2003 Apr;72(4):785-803. doi: 10.1086/374317. Epub 2003 Mar 7. Am J Hum Genet. 2003. PMID: 12629596 Free PMC article. Review.
-
PharmGKB summary: succinylcholine pathway, pharmacokinetics/pharmacodynamics.Pharmacogenet Genomics. 2015 Dec;25(12):622-30. doi: 10.1097/FPC.0000000000000170. Pharmacogenet Genomics. 2015. PMID: 26398623 Free PMC article. Review. No abstract available.
-
Neurological channelopathies.Postgrad Med J. 2005 Jan;81(951):20-32. doi: 10.1136/pgmj.2004.022012. Postgrad Med J. 2005. PMID: 15640425 Free PMC article. Review.
-
Screening for mutations in the RYR1 gene in families with malignant hyperthermia.J Mol Neurosci. 2003;21(1):35-42. doi: 10.1385/JMN:21:1:35. J Mol Neurosci. 2003. PMID: 14500992
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources